Endo Pharmaceuticals Sues Matrix Laboratories and Mylan

  • August 18, 2011

Endo Pharmaceuticals filed suit against Matrix Laboratories and Mylan over three patents related to tetrahydrocarbazole derivatives for use in the treatment of migraines.  8/16, District of Delaware, 1:2011cv00717.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×